Intermediate for Ticagrelor. Ticagrelor(trade name Brilinta, Brilique, and Possia) is a platelet aggregation inhibitor. Ticagrelor is an antagonist of the P2Y12 receptor. Ticagrelor has been approved by US FDA in on July 20, 2011.
Product Name: (1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride
CAS Number: 156491-10-9
Molecular Weight:  205.6345
Molecular Formula:  C9H10ClF2N
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.